SICAV Funds performance table

help icon
fund name 1 mth 3 mth 12 mthsort icon ytd Inception Net assets Return Date
Lyxor ETF MSCI World Info Tech TR C-EUR 5% 10% 33% 29% 17% 18M 2014-11-30
JPM Global Healthcare C (acc) - USD -3% 0% 33% 2% 7% 2515M 2014-04-30
Sixtina QIM C3 Fund EUR 26% 48% 33% 26% 3% - 2011-11-30
FMG (EU) MENA Fund B09 SEK 3% 10% 33% 7% 4% 111M 2014-02-28
Schroder ISF Middle East EUR I 0% 0% 33% 36% 7% 235M 2014-11-30
Threadneedle(Lux) Global Energy Eqs IU -5% -5% 33% 4% 8% 47M 2011-05-31
Parvest Equity France I 3% 7% 33% 9% 0% 43M 2013-05-31
SSgA Health Care Index Equity I EUR 3% 12% 33% 33% 27% 60M 2014-11-30
JPM US Dynamic I (inc) - EUR 0% 5% 33% 16% -2% 130M 2012-09-30
JPM US Growth I (acc)-JPY 7% 18% 33% 26% 37% 4295M 2014-11-30
db x-trackers S&P 500 2x Lev Dly 1C 5% 7% 33% 26% 27% 96M 2014-11-30
Lyxor ETF MSCI World Hlth Care TR C-EUR 3% 12% 33% 33% 22% 175M 2014-11-30
FMG (EU) MENA Fund B09 EUR 3% 9% 33% 7% 7% 13M 2014-02-28
Parworld Multi-Asset Booster I Plus 5% -1% 33% 34% 45% 35M 2014-11-30
Aviva Investors Japanese Equity I -3% 5% 32% -3% 0% 4295M 2014-01-31
AB SICAV International Technology I USD -1% 0% 32% 8% 10% 244M 2011-05-31
UBS (Lux) IS Small Caps Equity Europe XA -1% 6% 32% 6% 5% 27M 2014-03-31
Pictet Biotech-I dy GBP 4% 15% 32% 31% 20% 958M 2014-11-30
ING (L) Invest Biotechnology I USD -1% 6% 32% 13% -1% 49M 2011-06-30
Franklin Technology I Acc € 4% 9% 32% 27% 14% 719M 2014-11-30
Fidelity India Focus Y-Acc-USD 5% 13% 32% 25% 2% 1610M 2014-06-30
MS INVF US Growth Z USD -1% 4% 32% 9% 5% 1191M 2011-05-31
MS INVF Asian Equity Z -1% 10% 32% 4% 6% 480M 2011-05-31
Edgewood L Sel US Select Growth I EUR 2% 9% 32% 27% 8% 1456M 2014-11-30
Parworld Multi-Asset Booster I 5% -1% 32% 33% 33% 35M 2014-11-30
MS INVF US Growth IX USD -1% 4% 32% 9% 4% 1191M 2011-05-31
JPM Europe Small Cap C (acc)-EUR -3% 4% 32% 5% 9% 677M 2014-04-30
BNPP L1 Equity World Emerging I -2% 7% 31% 3% 16% 933M 2011-05-31
Investec GSF Glbl Growth I Inc Grs USD -1% 5% 31% 10% 2% 46M 2011-05-31
SGAM Fund Eqs AsiaPac Dual Strategies B -1% 9% 31% 4% 11% 85M 2011-05-31

All our data is licensed from Morningstar UK Ltd. Important legal information